| Today, Wed, Feb 10, 2010 | | • | Cel-Sci's CEO Drops South African Mystery Partner: BioBuzz
at TheStreet.com (Wed 6:11am)
| | Tue, Feb 9, 2010 | | • | [video] Stock Wrap: The Real Story, February 9
at TheStreet.com (Tue 4:52pm)
| | • | AstraZeneca Goes to the Well One Last Time
at Minyanville.com (Tue 12:50pm)
| | • | The New Danger for Foreign Investors?
at Motley Fool (Tue 11:22am)
| | • | Five Growth Stocks With a Margin of Safety
at TheStreet.com (Tue 5:00am)
| | Mon, Feb 8, 2010 | | • | Teva gets Nordic and Baltic rights for MS drug from Active Biotech
at bizjournals.com (Mon, Feb 8)
| | • | Teva, Active extend pact on oral MS therapy
at MarketWatch (Mon, Feb 8)
| | • | Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regions
Business Wire (Mon, Feb 8)
| | Fri, Feb 5, 2010 | | • | Teva Settles Lawsuits for $315 Million
at Fox Business (Fri, Feb 5)
| | • | [$$] Teva Reaches Preliminary Settlement In Drug Pricing Suit
at The Wall Street Journal Online (Fri, Feb 5)
| | • | Emerging-Market ETFs Still Have Steam
at TheStreet.com (Fri, Feb 5)
| | • | The Stocks You Need to Buy Now
at Motley Fool (Fri, Feb 5)
| | • | Teva Pharma settles some Medicaid drug price suits
AP (Fri, Feb 5)
| | • | UPDATE - Teva reaches settlement in drug pricing lawsuits
at Reuters (Fri, Feb 5)
| | • | Teva Announces Settlement in Principle regarding Certain Drug Pricing Lawsuits
Business Wire (Fri, Feb 5)
| | Thu, Feb 4, 2010 | | • | Earnings Growth Proves Drugmaker Made Right Moves
Investor's Business Daily (Thu, Feb 4)
| | • | Three Safe Stocks With Good Yield
RealMoney by TheStreet.com (Thu, Feb 4)
| | Wed, Feb 3, 2010 | | • | Teva, Amgen Duke It Out Over Generic Biotech
at The Wall Street Journal Online (Wed, Feb 3)
| | Tue, Feb 2, 2010 | | • | UPDATE - FDA to review Teva biosimilar of Amgen's Neupogen
at Reuters (Tue, Feb 2)
| | • | Cephalon Enters Generics Market
Zacks.com (Tue, Feb 2)
|
Add TEVA News to My Yahoo!:
 
| |
|
1.52% Nasdaq 0.00%
Headlines
